chr16-879711-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_022773.4(LMF1):​c.756G>A​(p.Ala252=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 1,597,650 control chromosomes in the GnomAD database, including 13,159 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1709 hom., cov: 33)
Exomes 𝑓: 0.12 ( 11450 hom. )

Consequence

LMF1
NM_022773.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.690
Variant links:
Genes affected
LMF1 (HGNC:14154): (lipase maturation factor 1) Involved in triglyceride metabolic process. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum membrane. Implicated in familial lipase maturation factor 1 deficiency. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 16-879711-C-T is Benign according to our data. Variant chr16-879711-C-T is described in ClinVar as [Benign]. Clinvar id is 1279701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-879711-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.69 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.261 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LMF1NM_022773.4 linkuse as main transcriptc.756G>A p.Ala252= synonymous_variant 6/11 ENST00000262301.16

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LMF1ENST00000262301.16 linkuse as main transcriptc.756G>A p.Ala252= synonymous_variant 6/115 NM_022773.4 P1Q96S06-1

Frequencies

GnomAD3 genomes
AF:
0.138
AC:
20992
AN:
151884
Hom.:
1703
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.209
Gnomad AMI
AF:
0.164
Gnomad AMR
AF:
0.0817
Gnomad ASJ
AF:
0.0744
Gnomad EAS
AF:
0.272
Gnomad SAS
AF:
0.133
Gnomad FIN
AF:
0.0661
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.114
Gnomad OTH
AF:
0.115
GnomAD3 exomes
AF:
0.118
AC:
25762
AN:
218024
Hom.:
1863
AF XY:
0.118
AC XY:
13897
AN XY:
118192
show subpopulations
Gnomad AFR exome
AF:
0.209
Gnomad AMR exome
AF:
0.0538
Gnomad ASJ exome
AF:
0.0756
Gnomad EAS exome
AF:
0.261
Gnomad SAS exome
AF:
0.127
Gnomad FIN exome
AF:
0.0740
Gnomad NFE exome
AF:
0.115
Gnomad OTH exome
AF:
0.0975
GnomAD4 exome
AF:
0.119
AC:
172443
AN:
1445648
Hom.:
11450
Cov.:
32
AF XY:
0.119
AC XY:
85281
AN XY:
717368
show subpopulations
Gnomad4 AFR exome
AF:
0.216
Gnomad4 AMR exome
AF:
0.0571
Gnomad4 ASJ exome
AF:
0.0793
Gnomad4 EAS exome
AF:
0.282
Gnomad4 SAS exome
AF:
0.122
Gnomad4 FIN exome
AF:
0.0785
Gnomad4 NFE exome
AF:
0.116
Gnomad4 OTH exome
AF:
0.120
GnomAD4 genome
AF:
0.138
AC:
21029
AN:
152002
Hom.:
1709
Cov.:
33
AF XY:
0.136
AC XY:
10074
AN XY:
74290
show subpopulations
Gnomad4 AFR
AF:
0.209
Gnomad4 AMR
AF:
0.0816
Gnomad4 ASJ
AF:
0.0744
Gnomad4 EAS
AF:
0.273
Gnomad4 SAS
AF:
0.132
Gnomad4 FIN
AF:
0.0661
Gnomad4 NFE
AF:
0.114
Gnomad4 OTH
AF:
0.115
Alfa
AF:
0.119
Hom.:
2313
Bravo
AF:
0.143
Asia WGS
AF:
0.258
AC:
895
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 04, 2018- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 11, 2018This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
8.6
DANN
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2076425; hg19: chr16-929711; COSMIC: COSV51894434; COSMIC: COSV51894434; API